Body weight |
BW |
kg |
70 (adult); 15 (child) |
[28] |
Average time |
AT |
days (d) |
ED × 365 (non-carcinogenic) |
[25,27,28] |
Exposure duration |
ED |
year (y) |
30 (adult); 6 (child) |
[27,28] |
Exposure frequency |
EF |
d/y |
350 |
[25,27,28] |
Exposure time |
ET |
h/d |
0.58 (adult), 1 (child) |
[28] |
Ingestion rate |
IR |
L/d |
2 (adult); 0.64 (child) |
[28] |
Exposed skin area |
SA |
cm2
|
18,000 (adult), 6600 (child) |
[28] |
Dermal permeability coefficient |
Kp
|
cm/h |
1 × 10−3 (As, Cd, Cu, Mn, Fe); 2 × 10−3 (Cr); 1 × 10−4 (Pb); 2 × 10−4 (Ni); 6 × 10−4 (Zn), 1 × 10−3 (NO3−) |
[25,27,28] |
Ingestion reference dose |
RfDing
|
µg/kg/d |
0.03 (As), 0.5 (Cd), 3.0 (Cr), 40 (Cu), 24 (Mn), 20 (Ni), 1.4 (Pb), 300 (Zn), 300 (Fe), 1600 (NO3−) |
[25,27,28] |
Dermal reference dose |
RfDdermal
|
µg/kg/d |
0.285 (As); 0.025 (Cd); 0.075 (Cr); 12 (Cu); 0.96 (Mn); 0.8 (Ni); 0.42 (Pb); 60 (Zn); 45 (Fe), 800 (NO3−) |
[25,27,28] |
Carcinogenic slope factor via ingestion |
SFing
|
µg/kg/d |
0.0015 (As) |
[25,28] |
Dermal contact slope factor |
SFdermal
|
µg/kg/d |
0.0036 (As) |
[25,28] |